Zedenoleucel

DB18639InvestigationalCell transplant therapies

MT-401 is an allogeneic multi-tumor-associated antigen-specific T-cell therapy.

Code names
MT-401

Resolves to

Compound
UNIIL4D9X59F34

What you can answer from here — as of October 28, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Zedenoleucel, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In